CDC panel needs more time to weigh risks of Johnson & Johnson's coronavirus vaccine
The CDC says it needs more time to weigh the risks of the Johnson & Johnson vaccine. An advisory panel met Wednesday but said it did not have enough information to make a decision, leaving a temporary pause on the vaccine in place. Dr. Amesh Adalja, an infectious disease expert and senior scholar at Johns Hopkins University's Bloomberg School of Public Health, joins CBSN's Lana Zak with more on the fate of the Johnson and Johnson vaccine. CBSN is CBS News’ 24/7 digital streaming news service featuring live, anchored coverage available for free across all platforms. Launched in November 2014, the service is a premier destination for breaking news and original storytelling from the deep bench of CBS News correspondents and reporters. CBSN features the top stories of the day as well as deep dives into key issues facing the nation and the world. CBSN has also expanded to launch local news streaming services in major markets across the country. CBSN is currently available on CBSNews.com and the CBS News app across more than 20 platforms, as well as the Paramount+ subscription service. Subscribe to the CBS News YouTube channel: http://youtube.com/cbsnews Watch CBSN live: http://cbsn.ws/1PlLpZ7c Download the CBS News app: http://cbsn.ws/1Xb1WC8 Follow CBS News on Instagram: https://www.instagram.com/cbsnews/ Like CBS News on Facebook: http://facebook.com/cbsnews Follow CBS News on Twitter: http://twitter.com/cbsnews Subscribe to our newsletters: http://cbsn.ws/1RqHw7T Try Paramount+ free: https://bit.ly/2OiW1kZ For video licensing inquiries, contact: licensing@veritone.com
View on YouTube
